A mechanistic analysis of spontaneous cancer remission phenomenon: identification of genomic basis and effector biomolecules for therapeutic applicability

[1]  Qing Yuan,et al.  Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker , 2022, Journal of oncology.

[2]  M. Gleave,et al.  Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics , 2021, Frontiers in Oncology.

[3]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[4]  D. G. Osborne,et al.  CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma. , 2018, Cancer research.

[5]  Friederike Ehrhart,et al.  CyTargetLinker app update: A flexible solution for network extension in Cytoscape , 2018, F1000Research.

[6]  Friederike Ehrhart,et al.  CyTargetLinker app update: A flexible solution for network extension in Cytoscape , 2018, F1000Research.

[7]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[8]  Herman Yeger,et al.  Combination therapy in combating cancer , 2017, Oncotarget.

[9]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[10]  T. Salman.  Spontaneous tumor regression , 2016 .

[11]  A. Sapino,et al.  Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis. , 2015, JAMA dermatology.

[12]  Ching-Seng Ang,et al.  FunRich: An open access standalone functional enrichment and interaction network analysis tool , 2015, Proteomics.

[13]  Wei Zhang,et al.  Topoisomerase IIα in Chromosome Instability and Personalized Cancer Therapy , 2014, Oncogene.

[14]  Youwei Zhang,et al.  Roles of Chk1 in cell biology and cancer therapy , 2014, International journal of cancer.

[15]  C. Branch,et al.  Mechanisms of Injury to Normal Tissue after Radiotherapy: A Review , 2014, Plastic and reconstructive surgery.

[16]  J. Bartlett,et al.  DNA repair and replication proteins as prognostic markers in melanoma , 2013, Histopathology.

[17]  B. Schmidt,et al.  The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage. , 2012, Journal of molecular biology.

[18]  J. Kirkwood,et al.  Immunotherapy of cancer in 2012 , 2012, CA: a cancer journal for clinicians.

[19]  H. Borghaei,et al.  Immunotherapy of cancer. , 2009, European journal of pharmacology.

[20]  V. Macdonald.  Chemotherapy: managing side effects and safe handling. , 2009, The Canadian veterinary journal = La revue veterinaire canadienne.

[21]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[22]  U. Del Monte.  Does the cell number 109 still really fit one gram of tumor tissue? , 2009, Cell cycle.

[23]  Ugo Del Monte,et al.  Does the cell number 10(9) still really fit one gram of tumor tissue , 2009 .

[24]  Angélique Marrau,et al.  Gene expression signature for spontaneous cancer regression in melanoma pigs. , 2008, Neoplasia.

[25]  Natasha K. Stout,et al.  Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model , 2006 .

[26]  A. M. Hicks,et al.  Transferable anticancer innate immunity in spontaneous regression/complete resistance mice , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Radunskaya,et al.  Mixed Immunotherapy and Chemotherapy of Tumors: Modeling, Applications and Biological Interpretations , 2022 .

[28]  A. A. Butov,et al.  Optimal control of the moment of spontaneous tumor regression , 2005 .

[29]  P. Shannon,et al.  Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks , 2003 .

[30]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[31]  Robert Kozma,et al.  From neurocomputation to immunocomputation - a model and algorithm for fluctuation-induced instability and phase transition in biological systems , 2002, IEEE Trans. Evol. Comput..

[32]  A. Barabasi,et al.  Lethality and centrality in protein networks , 2001, Nature.

[33]  Prasun Kumar Roy,et al.  Frank H. George Research Award winning paper Cancer self‐remission and tumour instability – a cybernetic analysis Towards a fresh paradigm for cancer treatment , 2000 .

[34]  K. Mclaren,et al.  Histological regression in primary cutaneous melanoma: recognition, prevalence and significance , 1992, Histopathology.

[35]  L. Freeman,et al.  Centrality in valued graphs: A measure of betweenness based on network flow , 1991 .

[36]  I. Tannock,et al.  Combined modality treatment with radiotherapy and chemotherapy. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  W. Cole.  Efforts to explain spontaneous regression of cancer , 1981, Journal of surgical oncology.

[38]  I. Vladimirova.  The Energetics of Regeneration Processes , 1978 .

[39]  T. Chou,et al.  Immunotherapy of cancer. , 1970, British medical journal.

[40]  Gert Sabidussi,et al.  The centrality index of a graph , 1966 .

[41]  Yi Pan,et al.  CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networks , 2015, Biosyst..

[42]  D. Lilley,et al.  DNA Repair , 1998, Nucleic Acids and Molecular Biology.